Non-peptidic natural products as ubiquitin-proteasome inhibitors

S Sengupta, G Mehta - Tetrahedron, 2019 - Elsevier
Approval of bortezomib has validated ubiquitin-proteasome pathway as an important target
for treatment of haematological malignancies. However, clinical shortcomings of bortezomib …
被引用次数：7 相关文章

[引用][C] Non-peptidic natural products as ubiquitin-proteasome inhibitors

S Sengupta, G Mehta - 2019